Form 8-K - Current report:
SEC Accession No. 0001558370-18-005108
Filing Date
2018-06-01
Accepted
2018-06-01 17:15:28
Documents
3
Period of Report
2018-05-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 57350
2 EX-3.1 ex-3d1.htm EX-3.1 5153
3 GRAPHIC ex-3d1g001.jpg GRAPHIC 386127
  Complete submission text file 0001558370-18-005108.txt   595339
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 18875983
SIC: 3841 Surgical & Medical Instruments & Apparatus